Wells Pharma of Houston LLC recalls Ketamine Hydrochloride Injectable Solution
- Recalling company
- Wells Pharma of Houston LLC
- Product
- Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.
- Reason
- cGMP deviations.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Apr 1, 2026
- Reported
- May 6, 2026
- Distribution
- U.S. Nationwide.
- Status
- Ongoing
- Quantity
- 4975 syringes
- Lot / codes
- 120925302312764, Exp Date 04/09/2026, 123125302312879 Exp Date, 05/05/2026, 123125302312880, Exp Date 05/05/2026, 010226302310003, Exp Date 05/06/2026, 010626302310007, Exp Date 05/08/2026, 010626302310008, Exp Date 05/08/2026 020426302310243, Exp Date 06/06/2026.
- Company location
- Houston, TX
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0507-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0507-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.